A detailed history of Boothbay Fund Management, LLC transactions in Alector, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 294,156 shares of ALEC stock, worth $482,415. This represents 0.02% of its overall portfolio holdings.

Number of Shares
294,156
Previous 44,400 562.51%
Holding current value
$482,415
Previous $207,000 168.12%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$1.72 - $6.06 $505,948 - $1.78 Million
294,156 New
294,156 $555,000
Q3 2021

Nov 15, 2021

SELL
$21.65 - $39.49 $1.68 Million - $3.07 Million
-77,811 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$15.5 - $22.48 $725,260 - $1.05 Million
46,791 Added 150.84%
77,811 $1.62 Million
Q1 2021

May 17, 2021

BUY
$14.84 - $22.23 $460,336 - $689,574
31,020 New
31,020 $625,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $135M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.